Nektar Therapeutics shares jumped 35.3% in extended trading Monday after the company said it would release topline results ...

Nektar Therapeutics said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin on Tuesday. Shares climbed 27% to $12.15 in after-hours trading Monday.

Shares of Nektar Therapeutics soared after the company said it would release topline data from a study of its atopic dermatitis treatment rezpegaldesleukin. The stock was up 31% at $12.49 in Monday's ...

On 16 June 2025, the Company announced that the board of directors had resolved on the Directed Issue I. Through the Directed Issue I, SciBase will receive proceeds of approximately SEK 19 million ...

Shea butter has historically been used for skin ailments for centuries. Learn the wide range of shea butter benefits and how ...

Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...

Signs of inflamed skin include a rash, itchiness, and excessive dryness. (8) There are several types of eczema. Atopic dermatitis is the most common type. Eczema is a complex condition. Your genes, ...

The biopharmaceutical company said Friday that the U.S. Food and Drug Administration has extended the review period by three months to Sept. 19, giving it more time to review additional chemistry, ...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ruxolitinib cream (Opzelura ® ...

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive ...

An itchy scalp may be related to your hair-washing schedule, but may stem from various other causes, including skin ...